MedTrace Logo

Pharmacokinetics of Epinephrine During Cardiac Arrest

NCT03036202 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 8

Last updated 2019-08-21

No results posted yet for this study

Summary

To determine the pharmacokinetics of epinephrine during cardiac arrest.

Conditions

  • Cardiac Arrest

Interventions

DRUG

Epinephrine

This is truly an observational study to determine T1/2 for epinephrine and time to peak concentration following a single dose of epinephrine in a cardiac arrest setting

Sponsors & Collaborators

  • Haukeland University Hospital

    lead OTHER

Principal Investigators

  • Baard E Heradstveit, MD, PhD · Haukeland University Hospital

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-26
Primary Completion
2018-07-12
Completion
2018-10-12
FDA Drug
Yes

Countries

  • Norway

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03036202 on ClinicalTrials.gov